We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Ian P Band has been assisting clients through the H1B Visa process since 2020.

As of 2022, Ian P Band has succesfully submitted and recieved certification for 187 cases.

Ian P Band is located in Washington, DC, and has represented 26 employers for the H1B Visa Process

215
Cases Handled
187
Cases Certified
86.98%
Approval

Cases Handled by Ian P Band

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-20281-866516 Certified Biochemists And Biophysicists Pharmaceutical And Medicine Manufacturing Genzyme Therapeutic Products Limited Partnership 2021
I-200-20112-503651 Certified Biochemists And Biophysicists Pharmaceutical And Medicine Manufacturing Genzyme Therapeutic Products Limited Partnership 2020
I-200-20111-501441 Certified Biochemists And Biophysicists Pharmaceutical And Medicine Manufacturing Sanofi Us Services Inc 2020
I-200-20111-501426 Certified Biochemists And Biophysicists Pharmaceutical And Medicine Manufacturing Sanofi Us Services Inc 2020
I-200-20056-348024 Certified Biochemists And Biophysicists Pharmaceutical And Medicine Manufacturing Genzyme Therapeutic Products Limited Partnership 2020
I-200-19343-186848 Certified Biochemists And Biophysicists Pharmaceutical And Medicine Manufacturing Genzyme Therapeutic Products Limited Partnership 2020
I-200-19339-181681 Certified Biochemists And Biophysicists Pharmaceutical And Medicine Manufacturing Genzyme Therapeutic Products Limited Partnership 2020
I-200-19319-149975 Certified Biochemists And Biophysicists Pharmaceutical And Medicine Manufacturing Genzyme Therapeutic Products Limited Partnership 2020
I-200-22168-293292 Certified Biochemists And Biophysicists Other Basic Inorganic Chemical Manufacturing Life Molecular Imaging Inc 2022
I-200-21167-404314 Certified Biologists Pharmaceutical And Medicine Manufacturing Bioverativ Therapeutics Inc 2021